For COVID-19 vaccine updates, please review our information guide and sign up for Connect. Continue your routine care with us by scheduling an in-person appointment or Video Visit.

News and Announcements

Dr. Ellen Scherl

Dr. Scherl Receives Prestigious Rosenthal Humanitarian Award from the Crohn’s and Colitis Foundation

On November 12, 2020, Dr. Ellen Scherl, the Jill Roberts Professor of Inflammatory Bowel Disease, Division of Gastroenterology and Hepatology, WDOM, was honored with the Rosenthal Humanitarian Award from the Crohn’s and Colitis Foundation.

As part of the Crohn’s and Colitis Foundation’s 53rd Annual Gala – known as “The Great...

Read More
IBD awareness ribbon

Podcast: Understanding Crohn's and Colitis Part One

In part one of this two-part series on Back to Health, Randy Longman M.D., Ph.D., and Dana Lukin MD, Ph.D., FACG discuss Crohn's Disease and Ulcerative Colitis. The panel discussion highlights the main risk factors, the first signs and symptoms, the triggers that can cause flare-ups, and...

Read More
lets gut real dr battat

Let's Gut Real Podcast: New ways to diagnose bile acid diarrhea with Dr Robert Battat

Bile acid diarrhea is a common cause of diarrhea in patients with IBS and IBD. Currently, our diagnostic tools are unaccessible and often, therapeutic trials with bile acid sequestrants are used in the diagnosis. In this informative podcast hosted by Canada’s Gut Health Dietitian, Andrea Hardy, Dr Robert Battat shares his research with a new diagnostic marker, C4, in the diagnosis and management of B.A.D., leading to more targeted care for patients. To listen to this podcast, please...

Read More

JRC physician discovers serum-based biomarker test for Crohn’s disease

JRC physician Dr. Robert Battat presented his findings at Digestive Disease Week 2019 demonstrating the efficacy of a serum-based biomarker assay in identifying mucosal inflammation with similar accuracy to fecal calprotectin in patients with Crohn’s disease

Dr. Longman Appointed to Director of the Jill Roberts Center for Inflammatory Bowel Disease (JRC)

Dr. Longman is widely recognized for his expertise and pioneering research in mechanisms by which the host immune system interacts with environmental triggers in both health and disease. The long-term goal of his research program is to discover microbial and cellular mechanisms that will lead to improved diagnostics for early detection of and novel therapies for IBD.

Researchers Identify Critical Role for Protein in Colon Inflammation

A protein induced by gut microbes is vital in healing colons that have become inflamed due to a short-term form of colitis, Weill Cornell Medicine researchers discovered in a new study. However, they also found that this molecule, called TNF-like ligand 1A (TL1A) contributes to the sustained inflammation characterized by chronic inflammatory bowel disease (IBD).

Fecal Microbiota Transplant is Safe and Effective for Patients with Ulcerative Colitis

Fecal microbiota transplantation (FMT) has been proven effective for patients with Clostridium difficile, a serious bacterial infection of the intestines, but questions remain about its effectiveness as a treatment for other diseases. In a study published April 26 in Inflammatory Bowel Disease, a team of...

Read More

JRC Physician Uncovers Bacteria Linking Crohn’s Disease to Arthritis

Patients with Crohn’s disease, a type of inflammatory bowel disease (IBD) that causes abdominal pain and diarrhea, can also experience joint pain. In Crohn’s disease, which affects about 800,000 Americans, the immune system can attack not only the bowels, but the musculoskeletal system as well, leading to spondyloarthritis, a painful condition that affects the spine and joints. Now new...

Read More
A. Webb Roberts Center for Continuing Medical Education of Baylor Health Care System, Dallas

Ellen J. Scherl, M.D., Speaks at ACG-Endorsed Course On IBD

JRC Director, Ellen J. Scherl, M.D., spoke at an ACG-endorsed course on inflammatory bowel disease (IBD) at Baylor University Medical Center in April. The conference focused on recent advances in IBD management, intervention, therapy and research. Dr. Scherl addressed the management of patients with severe ulcerative colitis in a lecture entitled “Severe Ulcerative Colitis: Identifying the High Risk Patient and Avoiding Colectomy”.

Read More
Jill Roberts IBD Center News

IBD Patients Say Symptoms Limit their Ability to Exercise

Despite the potential benefits of exercise for patients with inflammatory bowel disease (IBD), many patients experience “considerable barriers to regular exercise” because of debilitating IBD symptoms. Published in the January 2016 issue of Digestive Diseases and Sciences, these findings arose from a team of investigators led by Ellen J. Scherl, M.D., from the Jill Roberts Center for Inflammatory Bowel Disease at Weill Cornell Medicine.

Dr. Scherl and colleagues evaluated 250 patients...

Read More

Make an Appointment

(212) 746-5077

Weill Cornell Connect

Map this location

Jill Roberts Center for Inflammatory Bowel Disease
NewYork-Presbyterian Hospital
Weill Cornell Medical Center
1283 York Avenue
9th Floor
New York, NY 10065